Low-cost genome sequencing approach is powering genetics research on mental illness and many other studies

For researchers on the hunt for the genetic roots of disease, the cost of deep whole-genome sequencing makes it challenging ...
TMCnet

TAM Global Founder and Chief Scientific Advisor Publishes First-Principles Framework for Accelerating Translational Medicine

New commentary argues that the next breakthrough in medicine may come not only from discovering new therapies, but from redesigning the systems that bring them to patients NASHVILLE, Tenn., July 10, ...
JD Supra

HHS “Operation TrialBlazer” and the Future of U.S. Clinical Trial Access, Payment, and Infrastructure Reform

On June 22, 2026, the U.S. Department of Health and Human Services (HHS) “Operation TrialBlazer”, a coordinated, department-wide initiative to ...

Akari Therapeutics Appoints Former AACR President and Renowned Oncology Drug Development Leader, Patricia LoRusso, D.O., to Scientific Advisory Board

Globally recognized leader in early-phase oncology clinical development and experimental therapeuticsStrengthens strategic ...
BMJ Open

Severe Mental Illness Longitudinal Evaluation (SMILE): protocol for establishing a cohort and bioresource for UK-based patients with psychosis

Introduction Psychotic disorders account for significant morbidity and healthcare costs and yet their pathophysiology remains poorly understood. The National Institute for Health and Care Research ...
The Lancet

Novel strategies to overcome the blood–brain barrier in triple-negative breast cancer brain metastases

Triple-negative breast cancer—the most aggressive breast cancer subtype—has a high propensity for brain metastases, with ...

Molecular Instruments Advances Automated Multiplex Tissue Research with HCR™ Gold IF on the BOND RX Research Staining Instrument

Molecular Instruments® (MI), founded by the inventor of HCR™ technology, today announced the release of HCR™ Gold IF on the BOND RX research staining instrument from Leica Biosystems, a Danaher ...